| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director, 10% Owner | Director
3 companies
Hopfner Robert Lorne is a Director at Rallybio Corp with holdings across 3 companies. Recent SEC Form 4 filings include 2 buys and 40 sells.
Estimated insider holdings value: $108.6M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec 19, 2025 | EVMN Evommune, Inc. | Director, 10% Owner | Buy | 1,000 | $17.35 | $17,350.00 | +33.0% | +29.1% | - | |
| Aug 2, 2021 | RLYB Rallybio Corp | Director | Buy | 576,923 | $13.00 | $7,499,999.00 | +34.1% | +1.1% | -48.4% | |
| Feb 10, 2021 | PCVX Vaxcyte, Inc. | Director | Sell | 378,698 | $27.34 | $10,355,466.25 | -2.7% | - | - | |
| Feb 3, 2021 | PCVX Vaxcyte, Inc. | Director | Sell | 17,002 | $25.12 | $427,066.50 | -0.5% | - | - | |
| Jan 28, 2021 | PCVX Vaxcyte, Inc. | Director | Sell | 2,000 | $25.07 | $50,140.00 | -0.1% | - | - | |
| Jan 27, 2021 | PCVX Vaxcyte, Inc. | Director | Sell | 55,254 | $25.62 | $1,415,845.34 | -0.6% | - | - | |
| Jan 22, 2021 | PCVX Vaxcyte, Inc. | Director | Sell | 30,529 | $25.28 | $771,723.38 | -0.5% | - | - | |
| Jan 19, 2021 | PCVX Vaxcyte, Inc. | Director | Sell | 91,111 | $25.71 | $2,342,558.10 | -0.9% | - | - | |
| Jan 13, 2021 | PCVX Vaxcyte, Inc. | Director | Sell | 97,343 | $26.29 | $2,558,948.07 | -0.7% | - | - | |
| Jan 8, 2021 | PCVX Vaxcyte, Inc. | Director | Sell | 145,612 | $28.30 | $4,120,276.60 | -0.9% | - | - |